Thus, in addition to the greater prevalence of progressive ILD in CVID patients with TACI mutations there was apparently greater resistance to B cell depletive therapy, possibly due to elevated signaling through BAFF-R. Here, TNFRSF13C is linked to interstitial lung disease.